Outcomes of two trials of oxygen-saturation targets in preterm infants

Tarnow-Mordi, William, Stenson, Ben, Kirby, Adrienne, Juszczak, Edmund, Donoghoe, Mark, Deshpande, Sanjeev, Morley, Colin, King, Andrew, Doyle, Lex W., Fleck, Brian W., Davis, Peter G., Halliday, Henry L., Hague, Wendy, Cairns, Pamela, Darlow, Brian A., Fielder, Alistair R., Gebski, Val, Marlow, Neil, Simmer, Karen, Tin, Win, Ghadge, Alpana, Williams, Cathy, Keech, Anthony, Wardle, Stephen P., Kecskes, Zsuzsoka, Kluckow, Martin, Gole, Glen, Evans, Nicholas, Malcolm, Girvan, Luig, Melissa, Wright, Ian, Stack, Jacqueline, Tan, Kenneth, Pritchard, Margo, Gray, Peter H., Morris, Scott, Headley, Bevan, Dargaville, Peter, Simes, R. John and Brocklehurst, Peter (2016) Outcomes of two trials of oxygen-saturation targets in preterm infants. New England Journal of Medicine, 374 8: 749-760. doi:10.1056/NEJMoa1514212


Author Tarnow-Mordi, William
Stenson, Ben
Kirby, Adrienne
Juszczak, Edmund
Donoghoe, Mark
Deshpande, Sanjeev
Morley, Colin
King, Andrew
Doyle, Lex W.
Fleck, Brian W.
Davis, Peter G.
Halliday, Henry L.
Hague, Wendy
Cairns, Pamela
Darlow, Brian A.
Fielder, Alistair R.
Gebski, Val
Marlow, Neil
Simmer, Karen
Tin, Win
Ghadge, Alpana
Williams, Cathy
Keech, Anthony
Wardle, Stephen P.
Kecskes, Zsuzsoka
Kluckow, Martin
Gole, Glen
Evans, Nicholas
Malcolm, Girvan
Luig, Melissa
Wright, Ian
Stack, Jacqueline
Tan, Kenneth
Pritchard, Margo
Gray, Peter H.
Morris, Scott
Headley, Bevan
Dargaville, Peter
Simes, R. John
Brocklehurst, Peter
Title Outcomes of two trials of oxygen-saturation targets in preterm infants
Journal name New England Journal of Medicine   Check publisher's open access policy
ISSN 1533-4406
0028-4793
Publication date 2016-02-25
Sub-type Article (original research)
DOI 10.1056/NEJMoa1514212
Volume 374
Issue 8
Start page 749
End page 760
Total pages 12
Place of publication Waltham, United States
Publisher Massachussetts Medical Society
Collection year 2017
Language eng
Formatted abstract
BACKGROUND
The safest ranges of oxygen saturation in preterm infants have been the subject of debate.

METHODS
In two trials, conducted in Australia and the United Kingdom, infants born before 28 weeks' gestation were randomly assigned to either a lower (85 to 89%) or a higher (91 to 95%) oxygen-saturation range. During enrollment, the oximeters were revised to correct a calibration-algorithm artifact. The primary outcome was death or disability at a corrected gestational age of 2 years; this outcome was evaluated among infants whose oxygen saturation was measured with any study oximeter in the Australian trial and those whose oxygen saturation was measured with a revised oximeter in the U.K. trial.

RESULTS
After 1135 infants in Australia and 973 infants in the United Kingdom had been enrolled in the trial, an interim analysis showed increased mortality at a corrected gestational age of 36 weeks, and enrollment was stopped. Death or disability in the Australian trial (with all oximeters included) occurred in 247 of 549 infants (45.0%) in the lower-target group versus 217 of 545 infants (39.8%) in the higher-target group (adjusted relative risk, 1.12; 95% confidence interval [CI], 0.98 to 1.27; P = 0.10); death or disability in the U.K. trial (with only revised oximeters included) occurred in 185 of 366 infants (50.5%) in the lower-target group versus 164 of 357 infants (45.9%) in the higher-target group (adjusted relative risk, 1.10; 95% CI, 0.97 to 1.24; P = 0.15). In post hoc combined, unadjusted analyses that included all oximeters, death or disability occurred in 492 of 1022 infants (48.1%) in the lower-target group versus 437 of 1013 infants (43.1%) in the higher-target group (relative risk, 1.11; 95% CI, 1.01 to 1.23; P = 0.02), and death occurred in 222 of 1045 infants (21.2%) in the lower-target group versus 185 of 1045 infants (17.7%) in the higher-target group (relative risk, 1.20; 95% CI, 1.01 to 1.43; P = 0.04). In the group in which revised oximeters were used, death or disability occurred in 287 of 580 infants (49.5%) in the lower-target group versus 248 of 563 infants (44.0%) in the higher-target group (relative risk, 1.12; 95% CI, 0.99 to 1.27; P = 0.07), and death occurred in 144 of 587 infants (24.5%) versus 99 of 586 infants (16.9%) (relative risk, 1.45; 95% CI, 1.16 to 1.82; P = 0.001).

CONCLUSIONS
Use of an oxygen-saturation target range of 85 to 89% versus 91 to 95% resulted in nonsignificantly higher rates of death or disability at 2 years in each trial but in significantly increased risks of this combined outcome and of death alone in post hoc combined analyses. (Funded by the Australian National Health and Medical Research Council and others; BOOST-II Current Controlled Trials number, ISRCTN00842661, and Australian New Zealand Clinical Trials Registry number, ACTRN12605000055606.).
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 4 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 7 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 13 Mar 2016, 00:16:00 EST by System User on behalf of Learning and Research Services (UQ Library)